Related by context. All words. (Click for frequent words.) 79 hypoglycaemia 73 severe hypoglycemia 70 hypoglycemic episodes 70 hyperkalemia 69 hyperglycemia 68 Hypoglycemia 67 hypoglycemic events 66 fluid retention 66 nocturnal hypoglycaemia 66 hypoglycaemic 65 lactic acidosis 64 severe hypoglycemic 64 metabolic acidosis 64 blood sugar 63 hypotension 63 nocturnal hypoglycemia 63 hyperglycaemia 63 hyponatremia 63 extrapyramidal symptoms 62 thrombotic events 62 syncope 62 severe hypoglycaemia 62 hypoglycemic 61 thromboembolism 61 blood glucose levels 61 induced hypoglycemia 60 hypoglycemic coma 60 postprandial glucose 60 kidney dysfunction 60 Hypoglycaemia 60 serum potassium 59 hypercalcemia 59 hypoxemia 59 fluid overload 59 ketoacidosis 59 asthma exacerbations 59 renal insufficiency 59 daytime drowsiness 59 severe exacerbations 59 HbA1c levels 59 Hyperglycemia 59 vasovagal syncope 59 orthostatic hypotension 59 adrenal insufficiency 59 hypocalcemia 59 NPH insulin 59 reflux symptoms 59 torsades de pointes 59 acidosis 59 prolonged QT interval 59 triglyceride levels 59 microvascular complications 59 cerebrovascular events 59 thromboembolic events 58 GERD symptoms 58 decompensation 58 subclinical hypothyroidism 58 glycated hemoglobin levels 58 hypokalemia 58 hypovolemia 58 hypoglycaemic episodes 58 mmol L 58 OADs 58 arrhythmias 58 IBS symptoms 58 contrast induced nephropathy 58 thromboembolic 58 torsade de pointes 58 serum sodium 58 sedating antihistamine 58 elevated liver enzymes 58 postoperative AF 57 EXJADE 57 elevated blood glucose 57 tardive dyskinesia 57 hypertension 57 Hyponatremia 57 intracerebral hemorrhage 57 Severe hypoglycemia 57 RLS symptoms 57 elevated creatinine 57 akathisia 57 adrenal suppression 57 metformin accumulation 57 renal dysfunction 57 preeclampsia 57 hyperammonemia 57 febrile seizure 57 glycemia 57 hepatotoxicity 57 glycosylated hemoglobin HbA1c 57 hypomagnesemia 57 Ketoacidosis 57 albuminuria 57 hypoglycemia unawareness 57 recurrent VTE 57 A1C levels 57 baseline HbA1c 57 insulin detemir 57 vestibular dysfunction 57 proliferative diabetic retinopathy 57 autoimmune reactions 57 lamotrigine 57 ventricular tachycardia 57 macrovascular events 57 primidone 57 acute decompensation 57 tachycardia 56 hypos 56 postural hypotension 56 nocturnal awakenings 56 hypersensitivity reactions 56 Hypotension 56 postprandial insulin 56 parkinsonian symptoms 56 uncontrolled asthma 56 blood glucose 56 arterial thromboembolic events 56 malabsorption 56 gestational diabetes 56 GERD 56 plasma glucose levels 56 hyperbilirubinemia 56 fasting plasma glucose 56 uric acid levels 56 statin medications 56 lipid abnormalities 56 diabetic ketoacidosis DKA 56 A1C 56 hypersensitivity reaction 56 venous thrombosis 56 ventricular arrhythmia 56 ventricular arrhythmias 56 lowering blood glucose 56 microalbuminuria 56 salmeterol HFA MDI 56 reinfarction 56 Thrombocytopenia 56 rhythm disturbances 56 QT interval prolongation 56 febrile seizures 56 anaphylactic reaction 56 electrolyte abnormalities 56 intracerebral haemorrhage 56 serum cholesterol 56 unexplained fainting 56 renal toxicity 56 periprocedural 56 untreated sleep apnea 56 thyrotoxicosis 56 decompensated heart failure 56 COPD exacerbations 56 ACTOplus met 56 hypothyroid 56 hyponatraemia 55 bronchopulmonary dysplasia 55 corticosteroid therapy 55 potassium deficiency 55 anaphylactic reactions 55 hypothyroidism 55 tetany 55 atopic disease 55 serum potassium levels 55 ventricular fibrillation 55 hemoglobin A1c HbA1c 55 airway constriction 55 treatment emergent adverse 55 intracranial bleeding 55 exacerbations 55 Erythropoietic therapies may 55 clinically meaningful reductions 55 HbA1c 55 elevated uric acid 55 hypokalaemia 55 impaired renal 55 elevated ALT 55 edema swelling 55 lipid levels 55 proteinuria 55 triglycerides 55 left ventricular dysfunction 55 lispro 55 serum IGF 55 β blockers 55 Torsades de Pointes 55 antihypertensive medications 55 serum phosphate 55 impaired fasting glucose 55 insulin resistance 55 venous thromboembolism 55 alcoholic cirrhosis 55 adiponectin levels 55 tardive dyskinesia TD 55 tachyarrhythmias 55 infusion reactions 55 coadministration 55 potassium sparing diuretics 55 VIIBRYD 55 diabetes 55 prolactin levels 55 transaminase elevations 55 thyroxine 55 serum triglyceride levels 55 serum uric acid 55 MULTAQ 55 insulin glargine 54 acarbose 54 APTIVUS r 54 gastric acidity 54 improves glycemic 54 diabetes mellitus 54 Topiramate 54 Vitamin D insufficiency 54 HPA axis suppression 54 neuroleptics 54 dyskinesia 54 PMS symptoms 54 hemodilution 54 hyperthyroidism 54 QT prolongation 54 oxygen desaturation 54 Fasting plasma glucose 54 TEAEs 54 pulmonary embolus 54 B# deficiency 54 daytime sleepiness 54 magnesium intake 54 glycemic control 54 urinary retention 54 hypertensive patients 54 hepatic function 54 valproate 54 liver toxicity 54 overhydration 54 muscle cramps 54 drowsiness 54 myocardial infarction 54 euvolemic hyponatremia 54 upper gastrointestinal bleeding 54 apneic episodes 54 adjunctive ABILIFY 54 indomethacin 54 polypharmacy 54 glitazones 54 fatal myocardial infarction 54 febrile convulsions 54 syncopal 54 abnormal heartbeats 54 enuresis 54 thiazide diuretics 54 fasting glucose 54 abdominal adiposity 54 ALT elevations 54 amenorrhea 54 diabetic 54 recurrent atrial fibrillation 54 macrovascular 54 mg dL 54 myopathy rhabdomyolysis 54 HbA 1c 54 hemorrhagic complications 54 cardiac toxicity 54 bradycardia 54 diabetic complications 54 delayed gastric emptying 54 reflux 54 angina chest 54 untreated OSA 54 NovoLog ® Mix 54 hypoventilation 54 digestive discomfort 54 neuroleptic malignant syndrome 54 serum phosphate levels 54 A1c levels 54 TMP SMX 54 atrial fibrillation 54 hypercholesterolaemia 54 mg dl 54 leucopenia 54 SRBD 54 oral antidiabetes 54 MAO inhibitors 54 endometrial hyperplasia 54 vasomotor symptoms 54 generalized seizures 54 nighttime heartburn 54 ocular adverse 54 platelet inhibition 54 glucose 54 gout flares 54 aripiprazole 54 Vitamin B# deficiency 54 rimonabant #mg 54 loop diuretics 54 silent ischemia 54 bilirubin levels 54 gastric reflux 54 pancreatitis 54 ADHF 54 Hb A1C 54 PGTC seizures 54 receiving VELCADE 54 nonadherence 54 abrupt discontinuation 54 pernicious anemia 54 hypercapnia 54 intermittent hypoxia 54 solifenacin 54 conventional antipsychotics 54 Victoza R 54 symptomatic hypotension 54 bloodpressure 54 triglyceride concentration 54 glucose tolerance test 54 asthma exacerbation 54 fasting glucose levels 54 platelet reactivity 54 electrolyte imbalances 54 glargine 54 TNF antagonist 54 hemoglobin A1c levels 54 hyperprolactinemia 54 systolic BP 54 serum urate 54 ATACAND 54 neurodevelopmental impairment 54 stimulant medications 54 elevated LDL cholesterol 54 syncopal episode 54 MAOIs 54 recurrent UTI 54 heparin induced thrombocytopenia 54 serum calcium 54 Pancreatitis 54 pre eclampsia 54 blood Phe levels 54 glycaemia 54 HbA 1c levels 54 glycemic 54 acute pancreatitis 53 sudden cardiac death 53 nifedipine 53 hypoglycemic unawareness 53 hypercholesterolemia 53 severe neutropenia 53 OGTT 53 postoperative mortality 53 overactive bladder symptoms 53 impaired glucose tolerance 53 risperidone Risperdal 53 QTc intervals 53 NIASPAN 53 glycated hemoglobin HbA1c 53 neurologic complications 53 serotonin syndrome 53 lactase deficiency 53 ACTOplus met XR 53 variceal bleeding 53 hyperinsulinemia 53 POAG 53 QTc prolongation 53 intracranial hemorrhage ICH 53 oral antidiabetic medication 53 postsurgical complications 53 cardiac conduction 53 somnolence dizziness 53 hematologic adverse 53 phenytoin 53 LDL cholesterol levels 53 monoamine oxidase inhibitors 53 vasospasm 53 CMV infection 53 systemic corticosteroids 53 endotoxemia 53 apneic 53 JANUMET 53 serum creatinine levels 53 urinary oxalate 53 fasting blood glucose 53 caffeine intake 53 fainting episodes 53 Diabetic Ketoacidosis 53 Excessive daytime sleepiness 53 H2 blockers 53 Pioglitazone 53 VAPRISOL 53 angina 53 hydrops 53 overt nephropathy 53 hyperalgesia 53 cardiovascular mortality 53 pathologic fractures 53 cirrhotic patients 53 cognitive impairment 53 anaphylaxis 53 oral corticosteroids 53 acid secretion 53 NNT = 53 recurrent wheezing 53 diabetic gastroparesis 53 electrolyte disturbances 53 polycystic ovary syndrome 53 recurrent venous thromboembolism 53 sulfonylurea 53 postoperative nausea 53 postoperative delirium 53 obstructive sleep apnea 53 DVT PE 53 Hypocalcemia 53 hallucinations dyskinesia 53 primary aldosteronism 53 subcutaneous insulin 53 dysphagia 53 hematologic toxicity 53 renal impairment 53 detemir 53 intermittent claudication 53 lipid parameters 53 acute phosphate nephropathy 53 glucagon secretion 53 NAFLD 53 coagulopathy 53 hypervolemic hyponatremia 53 syncope fainting 53 allergic reactions 53 postoperative infections 53 Drowsiness 53 olanzapine 53 VT VF 53 comorbid conditions 53 hyperphenylalaninemia HPA due 53 hypersomnia 53 hepatic impairment 53 severe hypersensitivity reactions 53 insulin degludec 53 uncontrolled bleeding 53 cytopenias 53 psychotic symptoms 53 constipation nausea 53 salivary flow 53 nonfatal MI 53 post thrombotic syndrome 53 microvascular disease 53 recurrent ischemia 53 CrCl 53 induce orthostatic hypotension 53 cataract formation 53 density lipoprotein HDL cholesterol 53 ICD shocks 53 impaired cognition 53 strong CYP#A# inducers 53 Tardive dyskinesia 53 LDL C 53 xerostomia 53 noncardiovascular mortality 53 preterm delivery 53 elevated bilirubin 53 cerebral infarction 53 nephrotoxicity 53 fructose intolerance 53 mixed hyperlipidemia 53 Grass tetany 53 Peripheral edema 53 lowering homocysteine 53 serum leptin 53 venous blood clots 53 LDL cholesterol 53 delayed CINV 53 glucocorticoid 53 refractory ischemia 52 hepatic dysfunction 52 glucose intolerance 52 nausea diarrhea constipation 52 pioglitazone 52 intensive statin therapy 52 concomitant medications 52 febrile neutropenia 52 benazepril 52 antihypertensive therapy 52 vesicoureteral reflux 52 macrovascular disease 52 mild renal insufficiency 52 malignant hyperthermia 52 intraocular pressure 52 angioedema 52 Acute pancreatitis 52 RLAI 52 leptin resistance 52 bone marrow suppression 52 fasting triglycerides 52 underactive thyroid 52 sinus tachycardia 52 ventricular fibrillation VF 52 thyroid deficiency 52 carbohydrate cravings 52 hypoglycaemic unawareness 52 Cushing syndrome 52 pulmonary hypertension 52 tolvaptan 52 T2DM 52 valsartan 52 constipation 52 elevated homocysteine 52 gastrointestinal symptoms 52 bolus dose 52 homocysteine levels 52 hyperreflexia 52 pyloric stenosis 52 Hashimoto thyroiditis 52 HbA 1C 52 vitamin B# deficiency 52 systemic corticosteroid 52 QTc interval 52 T1DM 52 atopic eczema 52 hepatic toxicity 52 depressive symptoms 52 methemoglobinemia 52 nicardipine 52 Severe allergic reactions 52 mmol l 52 lumiracoxib 52 neurologic symptoms 52 sleepiness 52 alanine aminotransferase 52 cardiovascular disease 52 carotid stenosis 52 aminotransferases 52 gallstone formation 52 myoclonic seizures 52 hypo 52 tonic clonic movements 52 Clinically significant 52 abnormal lipids 52 gallstone disease 52 paroxysmal supraventricular tachycardia 52 placebo p 52 colorectal adenoma 52 PREZISTA r 52 convulsive seizures 52 coronary artery disease 52 nighttime awakenings 52 metabolic abnormalities 52 gouty arthritis 52 acute psychosis 52 overactive thyroid gland 52 beta blocker therapy 52 esophagitis 52 plasma triglycerides 52 urinary symptoms 52 CYP #A# 52 gastrointestinal bleeds 52 SGPT 52 adjunctive placebo 52 Stent thrombosis 52 cerebrovascular accident 52 myopathy 52 blood glucose concentrations 52 glimepiride 52 thrombocytopenia 52 sedating antihistamines 52 atherogenic dyslipidemia 52 polyp recurrence 52 insulin secretagogue 52 intravenous bisphosphonates 52 toxicities 52 Exacerbations 52 severe renal impairment 52 ventricular tachycardia VT 52 hypotensive 52 dosing frequency 52 reflux disease 52 sulphonylureas 52 AST ALT 52 beta agonists 52 allopurinol 52 serum glucose 52 omeprazole Prilosec 52 hemodynamic instability 52 nonfatal cardiovascular 52 carbohydrate intolerance 52 anaphylactic episodes 52 EFFEXOR XR 52 gastrointestinal bleeding 52 elevated triglyceride levels 52 diabetes mellitus T2DM 52 thyroid hormone levels 52 fragility fracture 52 #mg/day [002] 52 metabolic disturbances 52 postpartum hemorrhage 52 headache nausea fatigue 52 severe asthma exacerbations 52 status epilepticus 52 glomerular filtration 52 dyslipidaemia 52 Intussusception 52 glucose lowering 52 stent thrombosis 52 gastrointestinal distress 52 laboratory abnormalities 52 coronary disease 52 pyridostigmine 52 disordered breathing 52 neurological complications 52 acute renal failure 52 Thrombotic events 52 thrombophlebitis 52 plasma glucose 52 bronchospasm 52 anovulation 52 aldosterone antagonist 52 CLA supplementation 52 abdominal pain diarrhea 52 urine leakage 52 recurrent stroke 52 amiodarone 52 gastro oesophageal reflux 52 biphasic insulin aspart 52 hyperphosphatemia 52 Ileus 52 elevated serum creatinine 52 Fluid retention 52 dysrhythmias 52 nephrotoxic drugs 52 familial hypercholesterolemia 52 nighttime urination 52 serum calcium levels 51 phenobarbital phenytoin 51 incontinence episodes 51 oxygen saturation 51 tirofiban 51 overactive thyroid 51 HbA1C 51 dopamine antagonists 51 octreotide LAR 51 Thiazolidinediones 51 eclampsia 51 anticoagulants blood thinners 51 fructose diet 51 cerebral oxygenation 51 airway inflammation 51 urinary leakage 51 hepatic encephalopathy 51 neurodevelopmental outcome 51 cerebral vasospasm 51 tonic clonic seizures 51 Liver enzymes 51 vildagliptin 51 Calcium intake 51 necrotizing pancreatitis 51 unexplained syncope 51 serum sodium levels 51 myelosuppression 51 syncopal episodes 51 hyperparathyroidism 51 neurologic deficits 51 Oral corticosteroids 51 neurologic dysfunction 51 edema 51 BYSTOLIC 51 aldosterone antagonists 51 antiplatelet medications 51 hepatic insufficiency 51 atypical fractures 51 Valproate 51 hypovitaminosis D 51 hypophosphatemia 51 triacylglycerol concentrations 51 RSV infections 51 ketogenic diet 51 postoperative pulmonary 51 bladder contractions 51 nonsignificant 51 methimazole 51 oral corticosteroid 51 asymptomatic AF 51 dermatologic reactions 51 treatment emergent AEs 51 atopy 51 obstructive apnea 51 severe obstructive sleep 51 kidney function 51 pyelonephritis 51 metformin Glucophage 51 KALETRA 51 pentoxifylline 51 elevated triglycerides 51 Abdominal pain 51 rapid heartbeats 51 hyperhydrosis 51 fasting insulin 51 adrenal function 51 nondiabetics 51 moderate renal impairment 51 vertebral fracture 51 venous thromboembolic events 51 triglyceride concentrations 51 ropivacaine 51 Hypothyroidism 51 dapagliflozin plus 51 hyperpyrexia 51 vomiting PONV 51 anastomotic leak 51 thioridazine 51 elevated cortisol 51 INVEGA R 51 recurrent abdominal pain 51 Hyperthyroidism 51 HDL C 51 transferrin saturation 51 upper airway obstruction 51 RBP4 levels 51 postprandial hyperglycemia 51 prothrombotic 51 gastrointestinal GI 51 serum phosphorus 51 A1c 51 nausea constipation 51 ischemic cardiovascular 51 urinary calcium 51 nephropathy 51 cortisol secretion 51 dopaminergic therapy 51 desmopressin 51 symptomatic VTE 51 fasting triglyceride levels 51 tricyclic antidepressants 51 infarct size 51 coronary stenosis 51 somnolence sedation 51 QTc 51 alkalosis 51 postoperative complication 51 bone resorption 51 GH deficiency 51 acetaminophen overdose 51 ketoacidosis hyperosmolar coma 51 tapentadol ER 51 liver dysfunction 51 anemia hemoglobin 51 HbA1C levels 51 Lactic acidosis 51 calcium supplementation 51 elevated plasma concentrations 51 Mild hypothermia 51 cryptorchidism 51 antiplatelet drugs 51 neutropaenia 51 leukopenia 51 acute gout flares 51 acetabular dysplasia 51 ventilatory 51 Sleepiness 51 Febrile neutropenia 51 iron deficiency 51 thrombotic complications 51 acid reflux 51 transient ischemic attacks 51 heart disease 51 Generalized anxiety disorder 51 cardiac insufficiency 51 vertebral fractures 51 sotalol 51 hallucinations delirium 51 Digoxin toxicity 51 nonvertebral fracture 51 LEXIVA 51 atypical antipsychotic medications 51 venlafaxine Effexor 51 ADEs 51 hypercalciuria 51 blood lipids 51 lactose intolerance 51 discontinuations due 51 lightheadedness dizziness 51 premedication 51 thrombosis 51 pulmonary hypertension PH 51 coagulation abnormalities 51 euvolemic 51 amenorrhoea 51 OAB symptoms 51 postprandial glycemia 51 bronchoconstriction 51 warfarin 51 anticoagulation 51 OSAHS 51 alcoholic fatty liver 51 PRADAXA 51 Prediabetes 51 pericardial effusion 51 bronchial hyperresponsiveness 51 persistent pulmonary hypertension 51 clomipramine 51 polycystic ovary syndrome PCOS 51 hypoglycaemic attack 51 tranylcypromine 51 cardiovascular ischemic 51 autoantibody levels 51 liver enzymes 51 Wernicke encephalopathy 51 nonvertebral fractures 51 uncontrolled epilepsy 51 gastrointestinal disturbances 51 neural tube defect 51 perioperative complications 51 bad cholesterol LDL 51 frequent awakenings 51 VTE 51 asthma flare ups 51 antidiabetic medication 51 arrhythmia 51 myocardial infarctions 51 postoperative morbidity 51 gastric ulcers 51 thyroid dysfunction 51 subclinical hyperthyroidism 51 systolic hypertension 51 heart arrhythmias 51 ADHD symptoms 51 urate levels 51 urate lowering therapy 51 retinopathy 51 serum phosphorous 51 Glucocorticoids 51 dysglycemia 51 cranial irradiation 51 spontaneous preterm delivery 51 liver enzyme 51 folate intake 51 anticonvulsant drugs 51 extrapyramidal disorder 51 vasovagal 51 BPPV 51 unmeasured confounders 51 quinidine 51 hyperemesis gravidarum 51 anticholinergic effects 51 fat oxidation 51 cholesterol LDL C 50 Primary Hypercholesterolemia 50 renal scarring 50 quetiapine 50 ACTOS 50 gastroesophageal reflux 50 angiotensin II receptor blockers 50 aldosterone 50 Exacerbation 50 paroxysmal AF 50 salivary cortisol 50 Tylenol acetaminophen 50 gassiness 50 serum urate levels 50 menstrual migraines 50 carbohydrate intake 50 neutrophil counts 50 diuresis 50 triglycerides TG 50 NovoLog R 50 HPA axis 50 Obstructive sleep apnea 50 prolactin elevation 50 UTIs 50 nitrofurantoins 50 diastolic hypertension 50 cardiovascular 50 oral antidiabetic drugs 50 lipid lowering medications 50 somnolence fatigue 50 homozygous familial hypercholesterolemia 50 cerebral oxygen saturation 50 neuropsychiatric symptoms 50 systolic blood pressure 50 ECG abnormalities 50 cardiac dysfunction 50 analgesic medications 50 von Willebrand disease 50 plasma lipid 50 sleep apnea 50 thrombocytosis 50 chronic metabolic acidosis 50 leukotriene receptor antagonists 50 citalopram Celexa 50 thrombocytopenia neutropenia 50 Hyperkalemia 50 NovoMix ® 50 folic acid deficiency 50 paricalcitol 50 transient ischemic attack 50 metabolic syndrome 50 tHcy 50 comorbid disorders 50 DULERA 50 left ventricular hypertrophy 50 #.#mmol L [002] 50 triglyceride 50 airway narrowing 50 severe hepatic insufficiency 50 cholecystitis 50 unstable angina 50 PYY 50 unmeasured factors 50 Toxicities 50 neurodevelopmental outcomes 50 thromboembolic complications 50 pulmonary exacerbation 50 pramlintide 50 thiazide 50 impaired hepatic 50 allograft rejection 50 sustained ventricular tachycardia 50 primary hypercholesterolemia 50 lipid disorders 50 pulmonary exacerbations 50 ximelagatran 50 symptom exacerbation 50 ovulatory infertility 50 dose colchicine 50 nonfatal myocardial infarction MI 50 inhaled steroids 50 gastrointestinal adverse reactions 50 droperidol 50 failure ADHF 50 serum bilirubin 50 abruption 50 statin therapy 50 TZDs 50 myocardial infarction stroke 50 gestational diabetes mellitus 50 diabetic kidney 50 anaphylactoid reactions 50 neurologic sequelae 50 symptomatic hypoglycemia 50 emotional lability 50 nephrotoxic 50 valsartan amlodipine 50 TZD 50 hs CRP 50 generalized epilepsy 50 metformin 50 thrombotic 50 Apidra ® 50 serum triglycerides 50 airway reactivity 50 INVEGA ® 50 p = NS 50 1c HbA 1c 50 glyburide 50 macroalbuminuria 50 virologic failure 50 placebo p = 50 fluid intake 50 apnea hypopnea 50 postoperative atrial fibrillation 50 hemoptysis 50 serum retinol 50 nonfatal stroke 50 involuntary movements 50 angina pectoris 50 IDDM 50 emesis 50 convulsions coma 50 haemorrhagic stroke 50 angioneurotic edema 50 myocardial ischemia 50 Antacids 50 prodromal symptoms 50 kainate 50 ruboxistaurin 50 creatinine levels 50 polycystic ovarian syndrome 50 metabolic alkalosis 50 malabsorptive 50 Hypokalemia 50 systolic dysfunction 50 overt hypothyroidism 50 primary generalized tonic 50 ALT flares 50 dexmedetomidine 50 thromboprophylaxis 50 DFMO 50 ovarian hyperstimulation syndrome OHSS 50 nonhematologic adverse reactions 50 NATRECOR ® 50 tiotropium 50 recurrent DVT 50 gastric pH 50 artery stenosis 50 COPD exacerbation 50 drowsiness nausea 50 hypertensives 50 hip fractures 50 Syncope 50 PPIs 50 fat malabsorption 50 subarachnoid haemorrhage 50 bruxism 50 Reye syndrome rare